Congenital plasminogen activator inhibitor type 1 deficiency (Q39607): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Linked ICD 10 | |||
| Property / Linked ICD 10: D68.8 / rank | |||
Normal rank | |||
Latest revision as of 05:05, 13 August 2026
Congenital plasminogen activator inhibitor type 1 (PAI-1) deficiency is a disorder that causes premature lysis of haemostatic clots and a moderate bleeding syndrome. Spontaneous bleeding is rarely observed, whereas moderate haemorrhages of the knees, elbows, nose and gingiva are usually triggered by mild trauma. However, menstrual bleeding may be severe and a prolonged bleeding after surgery is common. The PAI-1 deficiency may be qualitative or quantitative, total or partial.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 3B50.1 |
||
| English | Congenital plasminogen activator inhibitor type 1 deficiency |
Congenital plasminogen activator inhibitor type 1 (PAI-1) deficiency is a disorder that causes premature lysis of haemostatic clots and a moderate bleeding syndrome. Spontaneous bleeding is rarely observed, whereas moderate haemorrhages of the knees, elbows, nose and gingiva are usually triggered by mild trauma. However, menstrual bleeding may be severe and a prolonged bleeding after surgery is common. The PAI-1 deficiency may be qualitative or quantitative, total or partial. |
Statements
CID11:3B50.1
0 references
dki-india-3B50.1
0 references
Concluído
0 references
13 August 2026
0 references
